NO20030295L - Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser - Google Patents

Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser

Info

Publication number
NO20030295L
NO20030295L NO20030295A NO20030295A NO20030295L NO 20030295 L NO20030295 L NO 20030295L NO 20030295 A NO20030295 A NO 20030295A NO 20030295 A NO20030295 A NO 20030295A NO 20030295 L NO20030295 L NO 20030295L
Authority
NO
Norway
Prior art keywords
valproic acid
manners
derivatives
treatment
bipolar disorders
Prior art date
Application number
NO20030295A
Other languages
English (en)
Other versions
NO20030295D0 (no
Inventor
Mitchell Shirvan
Meir Bialer
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Publication of NO20030295L publication Critical patent/NO20030295L/no
Publication of NO20030295D0 publication Critical patent/NO20030295D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20030295A 2000-07-21 2003-01-20 Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser NO20030295D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22010200P 2000-07-21 2000-07-21
PCT/US2001/023116 WO2002007677A2 (en) 2000-07-21 2001-07-20 Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder

Publications (2)

Publication Number Publication Date
NO20030295L true NO20030295L (no) 2003-01-20
NO20030295D0 NO20030295D0 (no) 2003-01-20

Family

ID=22822065

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030295A NO20030295D0 (no) 2000-07-21 2003-01-20 Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser

Country Status (16)

Country Link
US (2) US6555585B2 (no)
EP (1) EP1303289A4 (no)
JP (1) JP2004520263A (no)
KR (1) KR100843703B1 (no)
CN (1) CN1251758C (no)
AU (1) AU2001280699A1 (no)
CA (1) CA2416821A1 (no)
CZ (1) CZ2004266A3 (no)
HU (1) HUP0600526A2 (no)
IL (1) IL153942A0 (no)
MX (1) MXPA03000547A (no)
NO (1) NO20030295D0 (no)
NZ (1) NZ523917A (no)
PL (1) PL365588A1 (no)
WO (1) WO2002007677A2 (no)
ZA (1) ZA200300641B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004520263A (ja) * 2000-07-21 2004-07-08 テバ　ファーマシューティカル　インダストリーズ　リミティド 双極性障害における躁病を治療するためのバルプロ酸および２−バルプロエン酸アミド誘導体の使用
US20060223888A1 (en) * 2002-12-16 2006-10-05 Abbott Frank S Valproic acid analogues and pharmaceutical composition thereof
WO2004071421A2 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries Ltd. Sustained release formulation of n-(2-propylpentanoyl) glycinamide and related compounds
WO2004071424A2 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries, Ltd. Immediate release formulation of n-(2-propylpentanoyl)glycinamide
IL157751A0 (en) * 2003-02-28 2004-03-28 Yissum Res Dev Co New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them
IL156203A0 (en) * 2003-05-29 2003-12-23 Yissum Res Dev Co Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders
EP1491188A1 (en) * 2003-06-25 2004-12-29 G2M Cancer Drugs AG Topical use of valproic acid for the prevention or treatment of skin disorders
US20060004098A1 (en) * 2003-07-28 2006-01-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compounds useful for treating neurological disorders
EP1713486A4 (en) * 2003-12-02 2009-04-29 Sheldon Leslie James COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY
US20060025477A1 (en) * 2004-07-22 2006-02-02 Artman Linda D Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases
US20080234213A1 (en) * 2005-09-02 2008-09-25 Matthias Wabl Oncogenic regulatory RNAs for diagnostics and therapeutics
US7459280B2 (en) * 2006-02-27 2008-12-02 Picobella, Llc Methods for diagnosing and treating kidney cancer
US20080267977A1 (en) * 2007-04-26 2008-10-30 Friedrich-Alexander University Of Erlangen-Nuremberg Combined immunological agent and sensitizing agent for the treatment of cancer
CN111733231A (zh) 2014-02-05 2020-10-02 耶达研究及发展有限公司 用于治疗和诊断的微rna和包含所述微rna的组合物
CA3046297A1 (en) * 2016-12-14 2018-06-21 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder
IL282188A (en) 2021-04-08 2022-11-01 Yeda Res & Dev Combined use of ketamine and bretigabine for the treatment of psychiatric disorders

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU988188A3 (ru) 1973-12-14 1983-01-07 Эсакмадьяросаги Ведьимювек (Инопредприятие) Способ получени N,N-дизамещенных амидов карбоновых кислот
DE3010599A1 (de) 1979-03-22 1980-10-09 Continental Pharma Derivate von glycinamid, deren herstellung und verwendung
US4301176A (en) * 1980-08-18 1981-11-17 Warner-Lambert Company Method of administering calcium valproate
FR2489319A1 (fr) 1980-08-27 1982-03-05 Clin Midy Derives de l'acide amino-4 butyrique et les medicaments, actifs notamment sur le systeme nerveux central, en contenant
BE885303A (fr) 1980-09-19 1981-03-19 Continental Pharma Glycinamides
LU83729A1 (fr) * 1981-11-04 1983-09-01 Galephar Sels d'acide valproique,leur preparation et leur utilisation
DK373383A (da) 1982-08-20 1984-02-21 Midit Fremgangsmaade til fremstilling af omega-aminosyrederivater
US4913906B1 (en) 1985-02-28 2000-06-06 Yissum Res Dev Co Controlled release dosage form of valproic acid
IT1190133B (it) 1986-06-19 1988-02-10 Chiesi Farma Spa Derivati di acido valproico e di acido (e)-2-valproenoico,procedimento per la loro preparazione e relative composizioni farmaceutiche
DE3785667T2 (de) 1986-09-17 1994-07-21 Clintec Nutrition Co Zusatznahrung bzw. therapie für personen mit risiko oder in behandlung für arteriosklerotische vaskuläre, kardiovaskuläre und/oder thrombotische erkrankungen.
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
US5585358A (en) 1993-07-06 1996-12-17 Yissum Research Development Corporation Of The Hebrew University Of Jerusalem Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
BR9708254A (pt) 1996-03-25 1999-08-03 Lilly Co Eli Método para o tratamento da dor
IL121268A0 (en) 1997-07-09 1998-01-04 Dpharm Ltd Branched chain fatty acids their derivatives and use in the treatment of central nervous system disorders
JP2002518442A (ja) 1998-06-22 2002-06-25 アメリカン・バイオジェネティック・サイエンシズ・インコーポレーテッド 偏頭痛及び情動病の治療及び予防用バルプロ酸類似物の用法
JP2004520263A (ja) * 2000-07-21 2004-07-08 テバ　ファーマシューティカル　インダストリーズ　リミティド 双極性障害における躁病を治療するためのバルプロ酸および２−バルプロエン酸アミド誘導体の使用

Also Published As

Publication number Publication date
KR20030036610A (ko) 2003-05-09
MXPA03000547A (es) 2004-04-05
EP1303289A2 (en) 2003-04-23
JP2004520263A (ja) 2004-07-08
EP1303289A4 (en) 2009-08-05
PL365588A1 (en) 2005-01-10
KR100843703B1 (ko) 2008-07-04
CA2416821A1 (en) 2002-01-31
IL153942A0 (en) 2003-07-31
US20020103237A1 (en) 2002-08-01
US6555585B2 (en) 2003-04-29
CN1446097A (zh) 2003-10-01
CN1251758C (zh) 2006-04-19
AU2001280699A1 (en) 2002-02-05
ZA200300641B (en) 2004-01-26
WO2002007677A3 (en) 2002-05-30
US20030212142A1 (en) 2003-11-13
NZ523917A (en) 2004-11-26
WO2002007677A2 (en) 2002-01-31
HUP0600526A2 (en) 2006-11-28
NO20030295D0 (no) 2003-01-20
CZ2004266A3 (cs) 2005-02-16

Similar Documents

Publication Publication Date Title
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
NO20030295L (no) Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser
NO20001754L (no) Prostaglandinagonister og anvendelse derav for behandling av benforstyrrelser
PL361849A1 (en) Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
NO20022585D0 (no) Pyrrolidinacetamidderivat alene eller i kombinasjon for behandling av CNS-forstyrrelser
AU9287401A (en) Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
ATE455106T1 (de) Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
EE04854B1 (et) Oksabispidiinühendid, nende valmistamise meetod ning ravimvorm kasutamiseks südame arütmia raviks ja profülaktikaks
NO20031903L (no) Nye amidoalkylpiperidin- og amidoalkylpiperazinderivater for anvendelse vedbehandling av nervesystemlidelser
HK1045986B (zh) 含羥基二十碳四烯酸衍生物的合成劑及其用於治療乾眼病症的方法
NO20006506D0 (no) Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer
NO20032340D0 (no) Substituerte derivater av aminofuran-2-yl-eddiksyre og aminotien-2-yl-eddiksyre og deres anvendelse for behandling av migrene og smerte
ATE323685T1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
ITMI20010957A0 (it) Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
HK1057332A1 (en) Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders
EE200100527A (et) Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks
EP1150669A4 (en) FORMULATIONS ON L-ARGININE BASE FOR DISEASE TREATMENT AND USE THEREOF
NO985974D0 (no) Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
NO20010569D0 (no) Proteaseinhibitorer for anvendelse ved behandling av psoriasis
IL151493A0 (en) Use of dermaciclane for the treatment of anxiety and depression
AU2001254825A1 (en) Butenoic acids derivatives and their use in the treatment of rhinitis
DE60102471D1 (de) Indolderivate zur verwendung in der behandlung von zns-störungen
GB0007217D0 (en) Materials and methods relating to the treatment of leukaemias

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application